OBJECTIVES: To assess the effect of acute changes in serotonin (5-HT) synthesis using the acute tryptophan depletion (ATD) paradigm on gastrointestinal (GI) and mood symptoms in irritable bowel syndrome (IBS). METHODS: In a randomized double-blind crossover study, 29 subjects (18 patients with ROME II defined IBS and 11 age-matched controls) were studied under ATD and acute tryptophan increase (ATI) conditions. GI symptoms, mood and anxiety ratings, as well as plasma tryptophan concentrations were measured. RESULTS:Total (and free) plasma tryptophan concentrations decreased on the ATD day in patients (73%[82%]) and controls (73%[80%]), and increased on the ATI day in patients (59%[143%]) and controls (61%[381%]). Compared with the ATD day, IBS patients reported more GI symptoms on the ATI day at +210 (p < 0.001) and at +270 (p < 0.05) min post drink. IBS patients also reported less anxiety on the ATI day compared with the ATD day at +270 min (p < 0.001). ATD and ATI did not affect these ratings in control participants. IBS patients had a lower mood compared with controls (p < 0.05), but this did not differ between the ATI and ATD days in either group. CONCLUSIONS:IBS patients' GI and anxiety responses to changes in tryptophan load differ from controls. This suggests a difference in serotonergic functioning between these two groups and provides evidence to support the hypothesis that 5-HT dysfunction is involved in IBS.
RCT Entities:
OBJECTIVES: To assess the effect of acute changes in serotonin (5-HT) synthesis using the acute tryptophan depletion (ATD) paradigm on gastrointestinal (GI) and mood symptoms in irritable bowel syndrome (IBS). METHODS: In a randomized double-blind crossover study, 29 subjects (18 patients with ROME II defined IBS and 11 age-matched controls) were studied under ATD and acute tryptophan increase (ATI) conditions. GI symptoms, mood and anxiety ratings, as well as plasma tryptophan concentrations were measured. RESULTS: Total (and free) plasma tryptophan concentrations decreased on the ATD day in patients (73%[82%]) and controls (73%[80%]), and increased on the ATI day in patients (59%[143%]) and controls (61%[381%]). Compared with the ATD day, IBSpatients reported more GI symptoms on the ATI day at +210 (p < 0.001) and at +270 (p < 0.05) min post drink. IBSpatients also reported less anxiety on the ATI day compared with the ATD day at +270 min (p < 0.001). ATD and ATI did not affect these ratings in control participants. IBSpatients had a lower mood compared with controls (p < 0.05), but this did not differ between the ATI and ATD days in either group. CONCLUSIONS:IBSpatients' GI and anxiety responses to changes in tryptophan load differ from controls. This suggests a difference in serotonergic functioning between these two groups and provides evidence to support the hypothesis that 5-HT dysfunction is involved in IBS.
Authors: James R Templeman; Emma Thornton; Cara Cargo-Froom; Eli J Squires; Kelly S Swanson; Anna K Shoveller Journal: J Anim Sci Date: 2020-05-01 Impact factor: 3.159
Authors: J S Labus; E A Mayer; J Jarcho; L A Kilpatrick; T O C Kilkens; E A T Evers; W H Backes; R-J M Brummer; M A van Nieuwenhoven Journal: Gut Date: 2011-03-14 Impact factor: 23.059
Authors: Bryon W Petschow; Anthony T Blikslager; Eric M Weaver; Joy M Campbell; Javier Polo; Audrey L Shaw; Bruce P Burnett; Gerald L Klein; J Marc Rhoads Journal: World J Gastroenterol Date: 2014-09-07 Impact factor: 5.742
Authors: Chih Yin Hsiao; Hsin Chun Tsai; Mei Hung Chi; Kao Chin Chen; Po See Chen; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889
Authors: Gerard Clarke; Peter Fitzgerald; John F Cryan; Eugene M Cassidy; Eamonn M Quigley; Timothy G Dinan Journal: BMC Gastroenterol Date: 2009-01-20 Impact factor: 3.067